Agios Pharmaceuticals AGIO Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's deferred tax assets and other non-current assets?
- Agios Pharmaceuticals (AGIO) reported deferred tax assets and other non-current assets of $3.93M in Q1 2026.
- How has Agios Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Agios Pharmaceuticals's deferred tax assets and other non-current assets decreased by 16.7% year-over-year, from $4.72M to $3.93M.